Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
LYM Lyme non spécifié |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
1 |
vaccin recombinant contre la maladie de Lyme, 60 microg/1 mL, ampoule de 0,5 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
|
vaccin recombinant contre la maladie de Lyme, 6 microg/1 mL, ampoule de 5 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
|
Administration of Lyme disease vaccine |
Direct substance |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
1 |
Administration of Lyme disease vaccine |
Direct substance |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
1 |
Administration of Lyme disease vaccine |
Direct substance |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
1 |
vaccin recombinant contre la maladie de Lyme, 6 microg/1 mL, ampoule de 5 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
1 |
vaccin recombinant contre la maladie de Lyme, 60 microg/1 mL, ampoule de 0,5 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre la maladie de Lyme |
Inferred relationship |
Some |
1 |